Literature DB >> 25704426

Vein resections >3 cm during pancreatectomy are associated with poor 1-year patency rates.

Tsutomu Fujii1, Akimasa Nakao2, Suguru Yamada2, Masaya Suenaga2, Masashi Hattori2, Hideki Takami2, Yoshikuni Inokawa2, Mitsuro Kanda2, Hiroyuki Sugimoto2, Shuji Nomoto2, Kenta Murotani3, Yasuhiro Kodera2.   

Abstract

BACKGROUND: Resection of the superior mesenteric vein (SMV) and portal vein (PV) involved in pancreatic neoplasms improves the chances of complete tumor removal. No consensus exists, however, on the optimal reconstructive approach, and postoperative venous stenosis in the first 6 months to 1 year can cause patient morbidity. We investigated medium-term patency after direct, end-to-end venous anastomosis and evaluate predictive factors for stenosis or occlusion.
METHODS: We analyzed retrospectively the records of 810 patients who underwent pancreatectomy at our institution from January 2000 through April 2014, and 197 patients who underwent concurrent SMV/PV resection were selected. The venous anastomosis was assessed every 4 or 6 months postoperatively by the use of portography with computed tomography. Preoperative and intraoperative variables were evaluated for their possible association with the development of severe anastomotic stenosis (≥70% occlusion).
RESULTS: Among patients whose cancer did not recur during the 1-year follow-up period, 18 developed severe stenosis. Univariate analyses showed that operation time ≥520 minutes and length of SMV/PV resection ≥31 mm were associated with the development of severe anastomotic stenosis. Multivariate analysis showed that length of SMV/PV resection ≥31 mm was among independent predictors of medium-term, severe anastomotic stenosis (hazard ratio, 5.96; 95% confidence interval 1.79-22.69; P = .003).
CONCLUSION: Direct end-to-end anastomosis of the PV system is safe and offers patients with periampullary neoplasia improved chances of complete tumor excision. When tension-free anastomosis cannot be guaranteed, generally in cases requiring ≥31 mm of SMV/PV resection, venous autografting may decrease the likelihood of anastomotic stenosis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25704426     DOI: 10.1016/j.surg.2014.12.002

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  11 in total

1.  Clinical benefits of neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreatic head: an observational study using inverse probability of treatment weighting.

Authors:  Tsutomu Fujii; Sohei Satoi; Suguru Yamada; Kenta Murotani; Hiroaki Yanagimoto; Hideki Takami; Tomohisa Yamamoto; Mitsuro Kanda; So Yamaki; Satoshi Hirooka; Masanori Kon; Yasuhiro Kodera
Journal:  J Gastroenterol       Date:  2016-05-11       Impact factor: 7.527

2.  Benign Portal Vein Stenosis After Pancreaticoduodenectomy.

Authors:  Katsuhisa Ohgi; Teiichi Sugiura; Yusuke Yamamoto; Yukiyasu Okamura; Takaaki Ito; Ryo Ashida; Takeshi Aramaki; Katsuhiko Uesaka
Journal:  World J Surg       Date:  2019-10       Impact factor: 3.352

3.  Parachute technique for portal vein reconstruction during pancreaticoduodenectomy with portal vein resection in patients with pancreatic head cancer.

Authors:  Shoichi Irie; Ryuji Yoshioka; Hiroshi Imamura; Yoshihiro Ono; Takafumi Sato; Yosuke Inoue; Hiromichi Ito; Yoshihiro Mise; Yu Takahashi; Akio Saiura
Journal:  Langenbecks Arch Surg       Date:  2021-10-19       Impact factor: 2.895

4.  Portal Vein Stenting for Portal Vein Stenosis After Pancreatoduodenectomy: A Case Report.

Authors:  Teruhisa Sakamoto; Yosuke Arai; Masaki Morimoto; Masataka Amisaki; Naruo Tokuyasu; Soichiro Honjo; Keigo Ashida; Hiroaki Saito; Shinsaku Yata; Yasufumi Ohuchi; Yoshiyuki Fujiwara
Journal:  Yonago Acta Med       Date:  2018-09-26       Impact factor: 1.641

5.  Cold-stored cadaveric venous allograft for superior mesenteric/portal vein reconstruction during pancreatic surgery.

Authors:  Dyre Kleive; Audun E Berstad; Caroline S Verbeke; Sven P Haugvik; Ivar P Gladhaug; Pål-Dag Line; Knut J Labori
Journal:  HPB (Oxford)       Date:  2016-06-20       Impact factor: 3.647

6.  New Portal-Superior Mesenteric Vein Reconstructions Using First Jejunal Vein Flap in Pancreaticoduodenectomy.

Authors:  Nobuyuki Takemura; Kenji Miki; Tomoo Kosuge
Journal:  World J Surg       Date:  2016-06       Impact factor: 3.352

7.  Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter.

Authors:  Suguru Yamada; Tsutomu Fujii; Norimitsu Yabusaki; Kenta Murotani; Naoki Iwata; Mitsuro Kanda; Chie Tanaka; Goro Nakayama; Hiroyuki Sugimoto; Masahiko Koike; Michitaka Fujiwara; Yasuhiro Kodera
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

8.  Inverse Probability of Treatment Weighting Analysis of Upfront Surgery Versus Neoadjuvant Chemoradiotherapy Followed by Surgery for Pancreatic Adenocarcinoma with Arterial Abutment.

Authors:  Tsutomu Fujii; Suguru Yamada; Kenta Murotani; Mitsuro Kanda; Hiroyuki Sugimoto; Akimasa Nakao; Yasuhiro Kodera
Journal:  Medicine (Baltimore)       Date:  2015-09       Impact factor: 1.817

9.  Oral Food Intake Versus Fasting on Postoperative Pancreatic Fistula After Distal Pancreatectomy: A Multi-Institutional Randomized Controlled Trial.

Authors:  Tsutomu Fujii; Suguru Yamada; Kenta Murotani; Yukiyasu Okamura; Kiyoshi Ishigure; Mitsuro Kanda; Shin Takeda; Satoshi Morita; Akimasa Nakao; Yasuhiro Kodera
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

Review 10.  What Should Guide the Performance of Venous Resection During Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma with Venous Contact?

Authors:  Julie Navez; Christelle Bouchart; Diane Lorenzo; Maria Antonietta Bali; Jean Closset; Jean-Luc van Laethem
Journal:  Ann Surg Oncol       Date:  2021-01-21       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.